134 related articles for article (PubMed ID: 6666915)
1. [Acute psychoses and mood disorders in Parkinson disease. Role of antiparkinson therapy].
Mouren P; Poinso Y; Oppenheim G; Mouren A; Nguyen Quang N
Ann Med Psychol (Paris); 1983; 141(8):843-57. PubMed ID: 6666915
[TBL] [Abstract][Full Text] [Related]
2. [Acute pharmacotoxic psychoses in patients with chronic cerebral disorders].
Danielczyk W
Wien Med Wochenschr Suppl; 1979; 55():1-15. PubMed ID: 34935
[TBL] [Abstract][Full Text] [Related]
3. [Exogenous psychoses in Parkinson syndrome. Frequency and causal conditions].
Schneider E; Fischer PA; Jacobi P; Grotz A
Fortschr Neurol Psychiatr; 1984 Jun; 52(6):207-14. PubMed ID: 6745832
[TBL] [Abstract][Full Text] [Related]
4. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease.
Lin JJ; Yueh KC; Lin SZ; Harn HJ; Liu JT
J Neurol Sci; 2007 Jan; 252(2):130-4. PubMed ID: 17196621
[TBL] [Abstract][Full Text] [Related]
6. Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy.
Melamed E; Zoldan J; Friedberg G; Ziv I; Weizmann A
Adv Neurol; 1996; 69():545-50. PubMed ID: 8615179
[No Abstract] [Full Text] [Related]
7. Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease.
Duggal HS; Singh I
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):583-4. PubMed ID: 18022304
[No Abstract] [Full Text] [Related]
8. [Levodopa-induced psychosis in patients with idiopathic Parkinson disease].
García-Escrig M; Bermejo Pareja F; Fernández Ponsatí JT
Med Clin (Barc); 1999 Feb; 112(7):245-50. PubMed ID: 10220750
[TBL] [Abstract][Full Text] [Related]
9. Melperone in the treatment of iatrogenic psychosis in Parkinson's disease.
Barbato L; Monge A; Stocchi F; Nordera G
Funct Neurol; 1996; 11(4):201-7. PubMed ID: 8934152
[TBL] [Abstract][Full Text] [Related]
10. [Acute psychotic status after sudden interruption of treatment of Parkinsonism with levodopa].
Ledić P; Sepcić J; Antoncić N
Neurologija; 1977; 25(1-2):95-7. PubMed ID: 616879
[No Abstract] [Full Text] [Related]
11. [Hallucinations in Parkinson's disease].
Moser A; Hagenah J; Kömpf D
Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
[TBL] [Abstract][Full Text] [Related]
12. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
Kum WF; Gao J; Durairajan SS; Man SC; Xie LX; Lu JH; Fong WL; Li M
J Clin Neurosci; 2009 Aug; 16(8):1034-7. PubMed ID: 19428256
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacotoxic psychoses in patients with neurological disorders during old age (author's transl)].
Danielczyk W
Aktuelle Gerontol; 1979 Sep; 9(9):427-31. PubMed ID: 44122
[TBL] [Abstract][Full Text] [Related]
14. Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: an open-label, long-term study.
Meco G; Alessandri A; Giustini P; Bonifati V
Mov Disord; 1997 Jul; 12(4):610-2. PubMed ID: 9251085
[No Abstract] [Full Text] [Related]
15. Zotepine in levodopa-induced Psychosis.
Spieker S; Stetter F; Klockgether T
Mov Disord; 1995 Nov; 10(6):795-7. PubMed ID: 8750001
[No Abstract] [Full Text] [Related]
16. [Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (or phenomenon of priming)].
Damier P; Tremblay L; Féger J; Hirsch EC
Rev Neurol (Paris); 2000 Mar; 156(3):224-35. PubMed ID: 10740093
[TBL] [Abstract][Full Text] [Related]
17. Response to L-dopa and evolution of motor fluctuations in the early phase of treatment of Parkinson's disease.
Shif M; Kempster PA
Clin Exp Neurol; 1994; 31():38-42. PubMed ID: 7586663
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis.
Merello M; Nouzeilles MI; Arce GP; Leiguarda R
Mov Disord; 2002 Jul; 17(4):795-8. PubMed ID: 12210878
[TBL] [Abstract][Full Text] [Related]
19. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.
Hely MA; Morris JG; Reid WG; Trafficante R
Mov Disord; 2005 Feb; 20(2):190-9. PubMed ID: 15551331
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Parkinson's disease: levodopa as the first choice.
Katzenschlager R; Lees AJ
J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
